Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant β-catenin

Hepatology

Volumn 51, Issue 5, 2010, Pages 1603-1613

  Nejak Bowen, Kari N ^a   Thompson, Michael D ^a   Singh, Sucha ^a   Bowen Jr , William C ^a   Dar, Mohd Jamal ^a   Khillan, Jaspal ^a   Dai, Chunsun ^a   Monga, Satdarshan P S ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; DIETHYLNITROSAMINE; DNA; GLUTAMATE AMMONIA LIGASE; MUTANT PROTEIN; SERINE; THYMIDINE; WNT1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL CYCLE S PHASE; CELL GROWTH; CELL MEMBRANE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; HYDRODYNAMICS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL; LIVER REGENERATION; LIVER RESECTION; LIVER WEIGHT; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WESTERN BLOTTING; WILD TYPE;

ANIMALS; BETA CATENIN; DIETHYLNITROSAMINE; HEPATOCYTES; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MICE; MICE, TRANSGENIC; UP-REGULATION;

EID: 77951487860     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23538     Document Type: Article

References (47)

1. Thompson MD, Monga SP. WNT/beta-catenin signaling in liver health and disease. HEPATOLOGY 2007;45:1298-1305.
2. Benhamouche S, Decaens T, Godard C, Chambrey R, Rickman DS, Moinard C, et al. Apc tumor suppressor gene is the "zonation-keeper" of mouse liver. Dev Cell 2006;10:759-770.
3. Orsulic S, Huber O, Aberle H, Arnold S, Kemler R. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci 1999;112(Pt 8):1237-1245. (Pubitemid 29218912)
4. Monga SP, Pediaditakis P, Mule K, Stolz DB, Michalopoulos GK. Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. HEPATOLOGY 2001;33:1098-1109. (Pubitemid 32378208)
5. Sekine S, Gutierrez PJ, Lan BY, Feng S, Hebrok M. Liver-specific loss of beta-catenin results in delayed hepatocyte proliferation after partial hepatectomy. HEPATOLOGY 2007;45:361-368. (Pubitemid 46374592)
6. Sodhi D, Micsenyi A, Bowen WC, Monga DK, Talavera JC, Monga SP. Morpholino oligonucleotide-triggered beta-catenin knockdown compromises normal liver regeneration. J Hepatol 2005;43:132-141. (Pubitemid 40805284)
7. Tan X, Behari J, Cieply B, Michalopoulos GK, Monga SP. Conditional deletion of beta-catenin reveals its role in liver growth and regeneration. Gastroenterology 2006;131:1561-1572. (Pubitemid 44708943)
8. Cairo S, Armengol C, De Reynies A, Wei Y, Thomas E, Renard CA, et al. Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 2008;14:471-484.
9. de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A 1998;95:8847-8851. (Pubitemid 28350577)
10. Polakis P. Wnt signaling and cancer. Genes Dev 2000;14:1837-1851.
11. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. beta-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997;16:3797-3804. (Pubitemid 27280995)
12. Zeng G, Apte U, Cieply B, Singh S, Monga SP. siRNA-mediated betacatenin knockdown in human hepatoma cells results in decreased growth and survival. Neoplasia 2007;9:951-959. (Pubitemid 350086440)
13. Tan X, Apte U, Micsenyi A, Kotsagrelos E, Luo JH, Ranganathan S, et al. Epidermal growth factor receptor: a novel target of the Wnt/betacatenin pathway in liver. Gastroenterology 2005;129:285-302. (Pubitemid 41002061)
14. Ku NO, Michie S, Resurreccion EZ, Broome RL, Omary MB. Keratin binding to 14-3-3 proteins modulates keratin filaments and hepatocyte mitotic progression. Proc Natl Acad Sci U S A 2002;99:4373-4378. (Pubitemid 34285992)
15. Nejak-Bowen KN, Zeng G, Tan X, Cieply B, Monga SP. beta-Catenin regulates vitamin C biosynthesis and cell survival in murine liver. J Biol Chem 2009;284:28115-28127.
16. Yang J, Chen S, Huang L, Michalopoulos GK, Liu Y. Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth. HEPATOLOGY 2001;33:848-859. (Pubitemid 32246634)
17. Wang X, Quail E, Hung NJ, Tan Y, Ye H, Costa RH. Increased levels of forkhead box M1B transcription factor in transgenic mouse hepatocytes prevent age-related proliferation defects in regenerating liver. Proc Natl Acad Sci U S A 2001;98:11468-11473. (Pubitemid 32928752)
18. Legoix P, Bluteau O, Bayer J, Perret C, Balabaud C, Belghiti J, et al. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity. Oncogene 1999;18:4044-4046. (Pubitemid 29361344)
19. Hendriksen J, Jansen M, Brown CM, van der Velde H, van Ham M, Galjart N, et al. Plasma membrane recruitment of dephosphorylated beta-catenin upon activation of the Wnt pathway. J Cell Sci 2008;121:1793-1802. (Pubitemid 351943372)
20. Block GD, Locker J, Bowen WC, Petersen BE, Katyal S, Strom SC, et al. Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM) medium. J Cell Biol 1996;132:1133-1149. (Pubitemid 26105500)
21. Apte U, Singh S, Zeng G, Cieply B, Virji MA, Wu T, et al. Beta-catenin activation promotes liver regeneration after acetaminophen-induced injury. Am J Pathol 2009;175:1056-1065.
22. Goessling W, North TE, Lord AM, Ceol C, Lee S, Weidinger G, et al. APC mutant zebrafish uncover a changing temporal requirement for wnt signaling in liver development. Dev Biol 2008;320:161-174.
23. Albrecht JH, Rieland BM, Nelsen CJ, Ahonen CL. Regulation of G(1) cyclin-dependent kinases in the liver: role of nuclear localization and p27 sequestration. Am J Physiol 1999;277:G1207-1216.
24. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 1999;96:5522-5527. (Pubitemid 29234650)
25. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-426. (Pubitemid 29180374)
26. Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. HEPATOLOGY 2007;46:740-748. (Pubitemid 47436120)
27. Apte U, Zeng G, Thompson MD, Muller P, Micsenyi A, Cieply B, et al. beta-Catenin is critical for early postnatal liver growth. Am J Physiol Gastrointest Liver Physiol 2007;292:G1578-1585. (Pubitemid 47080611)
28. Tan X, Yuan Y, Zeng G, Apte U, Thompson MD, Cieply B, et al. Beta-catenin deletion in hepatoblasts disrupts hepatic morphogenesis and survival during mouse development. HEPATOLOGY 2008;47:1667-1679. (Pubitemid 351702749)
29. Hsu SC, Galceran J, Grosschedl R. Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin. Mol Cell Biol 1998;18:4807-4818. (Pubitemid 28343065)
30. Papkoff J, Aikawa M. WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells. Biochem Biophys Res Commun 1998;247:851-858. (Pubitemid 28418480)
31. Young CS, Kitamura M, Hardy S, Kitajewski J. Wnt-1 induces growth, cytosolic beta-catenin, and Tcf/Lef transcriptional activation in Rat-1 fibroblasts. Mol Cell Biol 1998;18:2474-2485. (Pubitemid 28183417)
32. Young CS, Masckauchan TN, Kitajewski J. beta-Catenin/Tcf activation partially mimics the transforming activity of Wnt-1 in Rat-1 fibroblasts. Differentiation 2003;71:477-485.
33. Monga SP. Role of Wnt/beta-catenin signaling in liver metabolism and cancer. Int J Biochem Cell Biol 2009 [Epub ahead of print].
34. Cadoret A, Ovejero C, Saadi-Kheddouci S, Souil E, Fabre M, Romagnolo B, et al. Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin. Cancer Res 2001;61:3245-3249. (Pubitemid 32695006)
35. Harada N, Miyoshi H, Murai N, Oshima H, Tamai Y, Oshima M, et al. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin. Cancer Res 2002;62:1971-1977. (Pubitemid 34408440)
36. Colnot S, Decaens T, Niwa-Kawakita M, Godard C, Hamard G, Kahn A, et al. Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas. Proc Natl Acad Sci U S A 2004;101:17216-17221. (Pubitemid 39627800)
37. Haramis AP, Hurlstone A, van der Velden Y, Begthel H, van den Born M, Offerhaus GJ, et al. Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia. EMBO Rep 2006;7:444-449.
38. Qian J, Sarnaik AA, Bonney TM, Keirsey J, Combs KA, Steigerwald K, et al. The APC tumor suppressor inhibits DNA replication by directly binding to DNA via its carboxyl terminus. Gastroenterology 2008;135:152-162. (Pubitemid 351899022)
39. Harada N, Oshima H, Katoh M, Tamai Y, Oshima M, Taketo MM. Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations. Cancer Res 2004;64:48-54. (Pubitemid 38114081)
40. Cieply B, Zeng G, Proverbs-Singh T, Geller DA, Monga SP. Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene. HEPATOLOGY 2009;49:821-831.
41. Hoshida Y, Nijman SM, Kobayashi M, Chan JA, Brunet JP, Chiang DY, et al. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res 2009;69:7385-7392.
42. Eferl R, Ricci R, Kenner L, Zenz R, David JP, Rath M, et al. Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 2003;112:181-192. (Pubitemid 36144108)
43. Umemura A, Itoh Y, Itoh K, Yamaguchi K, Nakajima T, Higashitsuji H, et al. Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma. HEPATOLOGY 2008;47:493-502. (Pubitemid 351280717)
44. Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, Ilyas M, et al. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci U S A 1999;96:1603-1608. (Pubitemid 29098498)
45. Reichling T, Goss KH, Carson DJ, Holdcraft RW, Ley-Ebert C, Witte D, et al. Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors. Cancer Res 2005;65:166-176. (Pubitemid 40070807)
46. Miyoshi H, Deguchi A, Nakau M, Kojima Y, Mori A, Oshima M, et al. Hepatocellular carcinoma development induced by conditional beta-catenin activation in Lkb1 mice. Cancer Sci 2009;100:2046-2053.
47. Liu Y, Tang MK, Cai DQ, Li M, Wong WM, Chow PH, Lee KK. Cyclin I and p53 are differentially expressed during the terminal differentiation of the postnatal mouse heart. Proteomics 2007;7:23-32. (Pubitemid 46173713)